Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
Shunqiang Li(Washington University in St. Louis), Ana M. González-Angulo(The University of Texas MD Anderson Cancer Center), Gordon B. Mills(The University of Texas MD Anderson Cancer Center), Michelle Harrison(Washington University in St. Louis), Rama Suresh(Washington University in St. Louis), Richard K. Wilson(Nationwide Children's Hospital), Dong Shen(Yancheng Second People's Hospital), Jeremy Hoog(Washington University in St. Louis), Laila Saied(Washington University in St. Louis), Katherine DeSchryver(Washington University in St. Louis), X. Cynthia(Washington University in St. Louis), Rodrigo Gonçalves(Southwestern Medical Center), Jingqin Luo(Washington University in St. Louis), Timothy Pluard(Southwestern Medical Center), César Sánchez(Pontificia Universidad Católica de Chile), Christopher Schlosberg(Washington University in St. Louis), Crystal Cooper(Washington University in St. Louis), Yi Dong(Yunnan Institute of Endemic Diseases Control and Prevention), Austin Lin(Washington University in St. Louis), Jin Zhang(Chongqing Cancer Hospital), Loren Michel(Washington University in St. Louis), R. McDowell(Washington University in St. Louis), Donna McEachern(University of Michigan), Rebecca Aft(Washington University in St. Louis), Xiaping He(University of North Carolina at Chapel Hill), Tom Mooney(Washington University in St. Louis), Caroline Bumb(Washington University in St. Louis), Robert S. Fulton(St. Jude Children's Research Hospital), William E. Gillanders(Washington University in St. Louis), Chanpheng Phommaly(Washington University in St. Louis), Sherri R. Davies(Washington University in St. Louis), Therese Giuntoli(Washington University in St. Louis), Shaomeng Wang(University of Michigan), Charles Lu(AbbVie (United States)), Joshua F. McMichael(Washington University in St. Louis), Megha Shyam Kavuri(Washington University in St. Louis), Michael Naughton(Boston College), Aleix Prat(Hospital Clínic de Barcelona), Wenbin Liu(Guangzhou University), Li Ding(Shenyang Agricultural University), Shuying Liu(Shandong University), Tao Yu(Washington University in St. Louis), Christopher A. Miller(Washington University in St. Louis), Jieya Shao(Washington University in St. Louis), Dave Larson(Broad Institute), Jeffrey Hiken(Cofactor Genomics (United States)), Robert T. Kitchens(Washington University in St. Louis), Obi L. Griffith(Washington University in St. Louis), Robert J. Crowder(University of Rochester), Ron Bose(University Hospitals Seidman Cancer Center)
Cited by 630
Related Papers
A global reference for human genetic variation
|Nature|2015|20.3k
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
|Nature|2008|7.8k
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
The B73 Maize Genome: Complexity, Diversity, and Dynamics
|Science|2009|4.2k
Oncogenic Signaling Pathways in The Cancer Genome Atlas
|Cell|2018|3.4k